Encore Tablets recalled by FDA, Bodee LLC
FDA, Bodee LLC issue nationwide recall of Encore Tablets
On-line pharmacy directory launched
Telephone and on-line directory company YellowPages is creating an on-line directory of pharmacies.
New form on the way for Schedules I & II drugs
DEA proposes a rule that would create a new format for ordering Schedule I and/or II controlled substances.
CMS to end e-prescription fax exemption
Beginning January 2009, computer-generated fax prescriptions will no longer be exempted from the requirement to meet the NCPDP SCRIPT standard according to CMS.
NIH to meet over use of hydroxyurea for sickle cell disease
Actor's newborn twins given overdose of blood thinner
State, county investigating error that led to high dose of heparin
National Influenza Vaccination Week promotes flu vaccinations
National influenza vaccination week encourages flu vaccinations
Hay fever nasal spray expands its population base
More pediatric patients can now use Omnaris Nasal Spray for hay fever
Caught selling outdated goods, chain agrees to settlement
Duane Reade has to pay thousands of dollars in restitution for selling expired over-the-counter products
Supermarket chain offers diabetes screenings by appointment
Supervalu is offering glucose screenings during the holiday season
CMS picks WellPoint for low-income program
CMS has selected WellPoint to administer its point-of-sale Part D enrollment program for low-income subsidized Medicare beneficiaries.
Reports of suicidal behavior may be linked to Pfizer's Chantix
FDA issues new information on varenicline (Chantix, Pfizer)
PhRMA encouraged by number of HIV therapies in development
92 new products in development for HIV/AIDS
Abilify gets agency nod as major depression add-on
Aripiprazole approved for depression
Fougera donates drugs to AmeriCares
Fougera donates topical steroids and antibiotics to countries in need via AmeriCares
Schering-Plough and Organon merger finalized
Schering-Plough/Organon merger passes antitrust scrutiny and is completed
Most Part D PDPs to list fewer drugs on their formulary for 2008
Many Medicare Part D patients will find fewer drugs to choose from in their drug plans' formularies in 2008
Schizophrenia drug gains new indication for maintenance treatment
Seroquel XR from AstraZeneca has gained a new indication: for maintenance treatment of schizophrenia in adults
DEA issues final rule on Schedule II Rxs
DEA has released its final rule allowing doctors to give patients multiple prescriptions for up to a 90-day supply of Schedule II narcotics
Lawsuit blames infant's death on OTC cough, cold products
Mother sues drugmakers over son's cold medication death
Oral drug approved to treat liver cancer
Nexavar gains new indication approval for liver cancer
ASCP selects MTM partner
The American Society of Consultant Pharmacists has selected PharmMD Solutions as a medication therapy management provider partner
Feds seize $2 million worth of 'cosmetic' eye product
FDA says product contains unapproved drug and could damage eye
Viewpoint: Reflections on pharmacy school after 30 years
Pharmacy schools' emphasis on chemistry is unjustified, according to this community pharmacist.
New products: November 19, 2007
New products include brand-name drugs, generics, home-health products, over-the-counter, and health and beauty care.
More PBMs agreeing to pricing transparency
Transparency in Pharmaceutical Purchasing Solutions: The HR Policy Association's Pharmaceutical Purchasing Coalition has 13 PBMs agreeing to five criteria creating pricing transparency for certification.
From pariah to patient
While boards of pharmacy are becoming less punitive in punishing addicted pharmacists, treatment options still vary from state to state.
150 Years of American Pharmacy: Red Book: From genesis to present
Druggists Circular and Drug Topics published The Red Book for close to 100 years to provide key drug pricing data to pharmacists.
Pharmacy schools confront new pressures
According to the American Association of Colleges of Pharmacy pharmacy schools are growing despite increased oversight and a pending faculty shortage.
First-in-class HIV treatment gets green light
Raltegravir, a new drug that inhibits integrase, the enzyme responsible for the insertion of HIV DNA into human DNA, was granted accelerated approval by the FDA.
